Together in HF

Novartis launches a social network for heart failure

When pharma giant Novartis first started marketing Entresto, a heart failure drug, it found itself facing criticism from cardiologists and consumers who felt the company’s direct-to-consumer ads were far too negative.

But following that criticism, Novartis has taken a much different approach to promoting Entresto.